JP2011512394A5 - - Google Patents

Download PDF

Info

Publication number
JP2011512394A5
JP2011512394A5 JP2010547251A JP2010547251A JP2011512394A5 JP 2011512394 A5 JP2011512394 A5 JP 2011512394A5 JP 2010547251 A JP2010547251 A JP 2010547251A JP 2010547251 A JP2010547251 A JP 2010547251A JP 2011512394 A5 JP2011512394 A5 JP 2011512394A5
Authority
JP
Japan
Prior art keywords
polyphosphate
use according
weight
content
wound healing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010547251A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011512394A (ja
Filing date
Publication date
Priority claimed from GB0803284A external-priority patent/GB0803284D0/en
Priority claimed from GB0803283A external-priority patent/GB0803283D0/en
Application filed filed Critical
Priority claimed from PCT/GB2009/000504 external-priority patent/WO2009104005A1/en
Publication of JP2011512394A publication Critical patent/JP2011512394A/ja
Publication of JP2011512394A5 publication Critical patent/JP2011512394A5/ja
Pending legal-status Critical Current

Links

JP2010547251A 2008-02-22 2009-02-23 慢性創傷の治療 Pending JP2011512394A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0803284A GB0803284D0 (en) 2008-02-22 2008-02-22 Enzyme inhibition
GB0803283A GB0803283D0 (en) 2008-02-22 2008-02-22 Enzyme inhibition
PCT/GB2009/000504 WO2009104005A1 (en) 2008-02-22 2009-02-23 Chronic wound treatment

Publications (2)

Publication Number Publication Date
JP2011512394A JP2011512394A (ja) 2011-04-21
JP2011512394A5 true JP2011512394A5 (OSRAM) 2013-08-01

Family

ID=40636998

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010547251A Pending JP2011512394A (ja) 2008-02-22 2009-02-23 慢性創傷の治療

Country Status (4)

Country Link
US (1) US20110117208A1 (OSRAM)
EP (1) EP2254585A1 (OSRAM)
JP (1) JP2011512394A (OSRAM)
WO (1) WO2009104005A1 (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5901021B2 (ja) 2010-01-20 2016-04-06 ケーシーアイ ライセンシング インク 流体潅流および／または陰圧閉鎖創傷療法のための、親水性フォーム状創傷挿入材を用いた漏出防止包帯システムおよび方法
WO2011125619A1 (ja) * 2010-04-08 2011-10-13 国立大学法人旭川医科大学 腸管保護剤
JP5528629B2 (ja) * 2011-07-19 2014-06-25 リジェンティス株式会社 酵母菌から抽出されたポリリン酸，ポリリン酸の塩又はポリリン酸の溶媒和物を含むポリリン酸組成物及びその製造方法。
DE102013222223A1 (de) * 2013-10-31 2015-04-30 Bk Giulini Gmbh Blutstillendes Mittel enthaltend kristallines Polyphosphat
GB2561262B (en) * 2017-07-13 2019-03-20 Dentmed Ltd A targeted drug delivery pad
WO2020039070A1 (en) * 2018-08-23 2020-02-27 Fibrothelium Gmbh Preparation of fibroin and therapeutic products made thereof
WO2020127745A1 (de) 2018-12-20 2020-06-25 Bk Giulini Gmbh Mittel zur behandlung blutender wunden

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3854326B2 (ja) * 1995-10-27 2006-12-06 株式会社ノエビア コラゲナーゼ阻害剤
JP2001064182A (ja) * 1999-08-26 2001-03-13 Nissho Corp スクラルファート懸濁液製剤
US6627785B1 (en) * 2000-02-29 2003-09-30 Virginia Commwealth University Wound dressings with protease-lowering activity
KR100338491B1 (ko) * 2000-03-30 2002-05-30 채수경 인중합체로 된 흉터 억제 및 상처 회복 촉진제
JP4428984B2 (ja) * 2003-10-29 2010-03-10 大正薬品工業株式会社 ベンズイミダゾール系化合物の安定化経口用組成物
JP5010143B2 (ja) * 2005-12-19 2012-08-29 リジェンティス株式会社 血管新生促進剤
JP5036252B2 (ja) * 2006-08-24 2012-09-26 リジェンティス株式会社 コラーゲンの産生を促進する剤、化粧料、及びコラーゲンの製造方法
GB2450477A (en) * 2007-06-18 2008-12-31 Ethicon Inc Stabilized wound dressing

Similar Documents

Publication Publication Date Title
JP2011512394A5 (OSRAM)
IL215275A0 (en) Pharmaceutical formulations and methods for treating respiratory tract infections
NZ597237A (en) Sublingual apomorphine
JP2010529999A5 (OSRAM)
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
JP2013520405A5 (OSRAM)
IL203448A (en) History of azabiphenylaminobenzoic acid for use in the treatment or prevention of a pathological condition or disease susceptible to reduction by dhodh inhibition and medicinal preparations containing them
MA30725B1 (fr) Administration d'inhibiteurs de la dipeptidyl peptidase
NZ605469A (en) Nalbuphine-based formulations and uses thereof
WO2011141929A3 (en) Aqueous pharmaceutical compositions of fluticasone and olopatadine
SI2760821T1 (en) A salt salt of an anti-inflammatory substituted cyclobutenedione compound
BR112013006597A2 (pt) tablete para desintegração oral em múltiplas camadas, e a fabricação do mesmo
MY174002A (en) Combination theraphy for the treatment of diabetes
JP2009537554A5 (OSRAM)
GEP201606513B (en) Pharmaceutical compositions for the treatment of cancer and other diseases or disorders
JP2014503593A5 (OSRAM)
EP2796450A4 (en) 6-AMINOPYRIDIN-3-OL DERIVATIVES OR PHARMACEUTICAL SALTS AND / OR PHARMACEUTICAL COMPOSITION THEREOF AS ACTIVE AGENTS FOR THE PREVENTION OR TREATMENT OF ANGIOGENESIS-MEDIATED DISEASES
PH12012501552A1 (en) Therapeutic or prophylactic agent for biliary diseases
MX351555B (es) Formas solidas de inhibidor de girasa (r)-1-etil-3-[5-[2-(1-hidrox i-1-metil-etil)pirimidin-5-il]-7-(tetrahidrofuran-2-il)-1h-benzim idazol-2-il]urea.
MX2014002480A (es) Uso del compuesto organico para el tratamiento del sindrome de noonan.
JP2018039810A5 (OSRAM)
WO2009084041A3 (en) Pharmaceutical compositions of dexibuprofen
TW201129386A (en) Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
HRP20110023T1 (hr) Smanjenje prekomjerne težine ili pretilosti
BR112014004732A2 (pt) composto benzotiazolona